psychedelicCultureSome People See Aliens While on DMT. Researchers Want to Find Out What They Can Teach UsBy Webb WrightScienceMicrodosing for Depression Appears to Work About as Well as Drinking CoffeeBy John SemleyCultureBryan Johnson Has Discovered Shrooms, and He Really Wants You to Know ItBy Mattha BusbyCultureCan Tech Get Rid of Bad Trips?By Michael Calore, Boone Ashworth, and Manisha KrishnanScienceWhy NFL All-Pros Are Turning to PsychedelicsBy John SemleyCulturePeople Are Using AI Chatbots to Guide Their Psychedelic TripsBy Mattha BusbyCultureDays-Long ‘Dark Retreats’ Are the Newest Spiritual Conquest for Tech ElitesBy Mattha BusbyThe Big StoryThe Epic Rise and Fall of a Dark-Web Psychedelics KingpinBy Andy GreenbergScienceThe Uncertain Path Forward for Psychedelic MedicineBy Emily MullinScienceThe FDA Just Rejected a Bid for MDMA to Treat PTSDBy Emily MullinScienceThey Had PTSD. A Psychedelic Called Ibogaine Helped Them Get BetterBy Emily MullinScienceCalifornia Nixes a Bill to Decriminalize Plant-Based PsychedelicsBy Celia FordScienceTo Understand the Human Brain, Give an Octopus MDMABy Gideon Lichfield and Lauren GoodeThe Big StoryMeet the Psychedelic Boom’s First RespondersBy Chris ColinThe Big StoryThe Psychedelic Scientist Who Sends Brains Back to ChildhoodBy Rachel NuwerScienceThe Therapy Part of Psychedelic Therapy Is a MessBy Grace BrowneScienceThe Harms of Psychedelics Need to Be Put Into ContextBy Grace BrowneScienceIs the Psychedelic Therapy Bubble About to Burst?By Grace BrowneThe Big StoryThe High-Stakes Race to Engineer New Psychedelic DrugsBy John SemleyIdeasHackers, Mason Jars, and the Science of DIY ShroomsBy Joanna SteinhardtScienceYour Brain Prefers Happy Endings. That’s Not Always SmartBy Sara HarrisonScienceThis Is My Brain on SalviaBy Daniel OberhausCultureNetflix’s Have a Good Trip Celebrates PsychedelicsBy Jennifer Ouellette, Ars TechnicaThe Big StoryThe Cosmic, Psychedelic, Glow-in-the-Dark Art of Alex AliumeBy Duff McDonaldMore Stories
